How big is the Latin America Biguanide Market?

The Latin America Biguanide Market size is expected to reach USD 386.66 million in 2024 and grow at a CAGR of 2.80% to reach USD 443.91 million by 2029. Read More

What is the current Latin America Biguanide Market size?

In 2024, the Latin America Biguanide Market size is expected to reach USD 386.66 million. Read More

Who are the key players in Latin America Biguanide Market?

Bristol-Myers Squibb, Boehringer Ingelheim, Merck and Co., Sanofi Aventis and Glenmark Pharmaceuticals are the major companies operating in the Latin America Biguanide Market. Read More

What years does this Latin America Biguanide Market cover, and what was the market size in 2023?

In 2023, the Latin America Biguanide Market size was estimated at USD 375.83 million. The report covers the Latin America Biguanide Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Latin America Biguanide Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Latin America Biguanide Market Share

Statistics for the 2023 & 2024 Latin America Biguanide market share, created by Mordor Intelligence™ Industry Reports. Latin America Biguanide share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Latin America Biguanide Industry

The Latin American biguanide market is fragmented, with manufacturers like Takeda, Merck, Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, Boehringer Ingelheim Pharmaceuticals, etc. having a global market presence, and the market is highly competitive due to generic drug manufacturers' presence.